The Treatment of Heterotopic Human Colon Xenograft Tumors in Mice with 5-Fluorouracil Attached to Magnetic Nanoparticles in Combination with Magnetic Hyperthermia Is More Efficient than Either Therapy Alone
Open Access
Abstract
Magnetic nanoparticles (MNPs) have shown promising features to be utilized in combinatorial magnetic hyperthermia and chemotherapy. Here, we assessed if a thermo-chemotherapeutic approach consisting of the intratumoral application of functionalized chitosan-coated MNPs (CS-MNPs) with 5-fluorouracil (5FU) and magnetic hyperthermia prospectively improves the treatment of colorectal cancer. With utilization of a human colorectal cancer (HT29) heterotopic tumor model in mice, we showed that the thermo-chemotherapeutic treatment is more efficient in inactivating colon cancer than either tumor treatments alone (i.e., magnetic hyperthermia vs. the presence of 5FU attached to MNPs). In particular, the thermo-chemotherapeutic treatment significantly (p < 0.01) impacts tumor volume and tumor cell proliferation (Ki67 expression, p < 0.001) compared to the single therapy modalities. The thermo-chemotherapeutic treatment: (a) affects DNA replication and repair as measured by H2AX and phosphorylated H2AX expression (p < 0.05 to 0.001), (b) it does not distinctly induce apoptosis nor necroptosis in target cells, since expression of p53, PARP cleaved-PARP, caspases and phosphorylated-RIP3 was non-conspicuous, (c) it renders tumor cells surviving therapy more sensitive to further therapy sessions as indicated by an increased expression of p53, reduced expression of NF-κB and HSPs, albeit by tendency with p > 0.05), and (d) that it impacts tumor vascularity (reduced expression of CD31 and αvβ3 integrin (p < 0.01 to 0.001) and consequently nutrient supply to tumors. We further hypothesize that tumor cells die, at least in parts, via a ROS dependent mechanism called oxeiptosis. Taken together, a very effective elimination of colon cancers seems to be feasible by utilization of repeated thermo-chemotherapeutic therapy sessions in the long-term.Keywords
Funding Information
- Deutscher Akademischer Austauschdienst (Forschungsstipendien - Promotionen in Deutschland, 2015/16 – Funding ID: 57129429)
This publication has 61 references indexed in Scilit:
- NF-?B addiction and resistance to 5-fluorouracil in a multi-stage colon carcinoma modelInt. Journal of Clinical Pharmacology and Therapeutics, 2013
- DNA damage induces reactive oxygen species generation through the H2AX-Nox1/Rac1 pathwayCell Death & Disease, 2012
- A multicenter phase II clinical study of oxaliplatin, folinic acid, and 5-fluorouracil combination chemotherapy as first-line treatment for advanced colorectal cancer: A Japanese experienceSurgery Today, 2011
- v Integrins in Angiogenesis and CancerCold Spring Harbor Perspectives in Medicine, 2011
- Rosiglitazone enhances the radiosensitivity of p53-mutant HT-29 human colorectal cancer cellsBiochemical and Biophysical Research Communications, 2010
- DNA damage-induced reactive oxygen species (ROS) stress response in Saccharomyces cerevisiaeFree Radical Biology and Medicine, 2008
- Soluble histone H2AX is induced by DNA replication stress and sensitizes cells to undergo apoptosisMolecular Cancer, 2008
- The DNA Damage Response: Ten Years AfterMolecular Cell, 2007
- Interaction between ATM and PARP-1 in response to DNA damage and sensitization of ATM deficient cells through PARP inhibitionBMC Molecular Biology, 2007
- The cellular and molecular basis of hyperthermiaCritical Reviews in Oncology/Hematology, 2002